Tag Archives: Antibody Drug Conjugation

14Apr/23

Introduction to Antibody-Drug Conjugates

April 14, 2023Biological KnowledgeAntibody Drug Conjugation, monoclonal antibody, Therapeutic Antibodybiolabs

Basic Structure of ADCs Antibody-drug conjugates (ADCs) are conjugates consisting of three basic components: monoclonal antibodies (which target specific tumor antigens), highly potent cytotoxic small molecule payloads, and linkers. The basic structureRead More…

22Nov/17

Collaboration to Evaluate Combination of Nivolumab + Brentuximab Vedotin in Phase III Trial in Relapsed Hodgkin Lymphoma Expanded

November 22, 2017Antibody Engineering Research, NewsADC, Antibody Drug Conjugationbiolabs

“Brentuximab Vedotin (Antibody-drug conjugate, ADC)was approved by the FDA in 2011 as the first new therapeutic option for patients with Hodgkin lymphoma in more than 30 years. Currently, brentuximab vedotin and nivolumabRead More…

Drug Discovery Research
Immunotherapy Research
Antibody Engineering Research